INS and type 2 diabetes mellitus: De Jager et al. have shown that in patients with type 2 diabetes treated with insulin, metformin treatment was associated with improvement of endothelial function by decreasing expression of VCAM-1, E-selectin and PAI-1, which were not related to changes in glycemic control [341].